BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 94 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $241,000 | +382.0% | 14,258 | +20.2% | 0.00% | – |
| Q4 2019 | $50,000 | +11.1% | 11,866 | +0.8% | 0.00% | – |
| Q3 2019 | $45,000 | -2.2% | 11,766 | 0.0% | 0.00% | – |
| Q2 2019 | $46,000 | -9.8% | 11,766 | 0.0% | 0.00% | – |
| Q1 2019 | $51,000 | +24.4% | 11,766 | 0.0% | 0.00% | – |
| Q4 2018 | $41,000 | -6.8% | 11,766 | 0.0% | 0.00% | – |
| Q3 2018 | $44,000 | -4.3% | 11,766 | 0.0% | 0.00% | – |
| Q2 2018 | $46,000 | +24.3% | 11,766 | 0.0% | 0.00% | – |
| Q1 2018 | $37,000 | -19.6% | 11,766 | 0.0% | 0.00% | – |
| Q4 2017 | $46,000 | – | 11,766 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABNER HERRMAN & BROCK LLC | 239,000 | $2,679,000 | 0.48% |
| EAM Investors, LLC | 81,854 | $918,000 | 0.20% |
| CFO4Life Group, LLC | 12,003 | $135,000 | 0.05% |
| Phoenix Holdings Ltd. | 104,782 | $1,112,000 | 0.05% |
| WINTON GROUP Ltd | 118,487 | $1,328,000 | 0.03% |
| Merit Financial Group, LLC | 28,731 | $322,000 | 0.03% |
| HighPoint Advisor Group LLC | 13,533 | $151,000 | 0.03% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 23,000 | $258,000 | 0.02% |
| ETF MANAGERS GROUP, LLC | 52,216 | $579,000 | 0.02% |
| IHT Wealth Management, LLC | 13,000 | $146,000 | 0.02% |